Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
PR Newswire Asia
· "Aiming to offer a Dengue antiviral treatment course in $100 price range"
· Hyundai Bioscience decides to conduct dengue..
· "Aiming to offer a Dengue antiviral treatment course in $100 price range"
· Hyundai Bioscience decides to conduct dengue..
Initial Data from Ongoing MyPeak™-1 Phase 1b of TN-201 for MYBPC3-associated HCM Expected in Second Half of 2024On Track to Dose..
Berlin, Germany/Research Triangle Park, North Carolina, USA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- *Not intended for UK..